Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Ketamine for Acute Suicidal Ideation in Emergency Setting
NCT02183272Phase 3Unknown
- Sponsor
- University of Cincinnati
- Start
- Aug 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in suicidal ideation, major depressive disorder (MDD), sponsored by University of Cincinnati. Status: unknown.
02
Drugs
ketamine
03
Conditions
suicidal ideationmajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02183272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183272.